Project Grant RF1AG091846
Award Date
9/30/24
Completion Date
8/31/27
Dollars Obligated
$1.9M
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Boston, MA 02115, USA
Similar Awards
The $925,344 Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to Brigham & Womens Hospital Inc. will support research to "MODULATE MICROGLIA AND ASTROCYTES TO TREAT ALZHEIMER'S DISEASE AND RELATED DEMENTIAS". The 3-year grant, awarded on April 15, 2024, will fund innovative biomedical research focused on developing new treatments for Alzheimer's disease and other neurodegenerative conditions by investigating the...
This $1,611,000 federal Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) to Brigham & Women's Hospital Inc. aims to illuminate the role of somatic mutations in the development of primary tauopathies, a group of neurodegenerative diseases including Alzheimer's. The project will leverage single-cell whole-genome sequencing of human brain tissue to examine somatic mutations in neurons and glia, as well as utilize cellular models to dissect mechanisms...
Brigham & Women's Hospital Inc. was awarded a $379,876 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 1, 2023 through August 31, 2026 to investigate whether microbiome-derived cell fragments in the brain can accelerate the transition from traumatic brain injury to Alzheimer's disease or related dementias. As the direct awardee, Brigham & Women's Hospital will leverage...
This federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) provides $2,173,794 to The General Hospital Corporation (Massachusetts General Hospital) to conduct research on enhancing brain resilience to Alzheimer's disease by targeting adult hippocampal neurogenesis. The project aims to explore the mechanisms by which adult hippocampal neurogenesis cooperates with brain-derived neurotrophic factor (BDNF) to potentially slow cognitive decline in...
This federal Project Grant award of $999,999.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The funding supports advanced biomedical research by Brigham & Women's Hospital, a prominent academic medical center and research institution, to investigate EBV signatures in relapsing and progressive forms of multiple sclerosis. The research project will be conducted over a period of approximately 3 years, from Aug 1, 2025 to...
Brigham & Women's Hospital Inc. was awarded a $1,859,665 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 1, 2023 to August 31, 2027 to investigate environmental and gut-brain axis determinants of cognitive outcomes in Parkinson's disease. As the primary awardee, Brigham & Women's Hospital will leverage its expertise in biomedical research to advance understanding of how...
This federal Project Grant award of $718,829.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research on the use of ergothioneine and its analog ovothiol A to target traumatic brain injury and comorbid alcohol use disorder. The award was granted to Brigham & Women's Hospital Inc., a prominent academic medical center and research institution in Boston, Massachusetts. The research project aims to investigate...
Brigham & Women's Hospital Inc. was awarded a $596,016 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 1, 2023 to August 31, 2027 to investigate environmental and gut-brain axis determinants of cognitive outcomes in Parkinson's disease. As the primary awardee, Brigham & Women's Hospital will leverage its expertise in biomedical research and healthcare services...
This $8.7 million project grant from the National Institutes of Health's National Institute on Aging will fund research into elucidating pathophysiology and improving biomarkers for Alzheimer's disease. The Brigham and Women's Hospital will leverage heterogeneity in autosomal dominant Alzheimer's disease to systematically characterize gamma-secretase function across pathogenic variants in presenilin-1, a key enzyme in amyloid beta production. Findings will be compared to cognitive and...
This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $566,810.00 to Brigham & Women's Hospital Inc., a non-profit hospital and research institution in Boston, MA, to support research on the neural regulation of small cell lung cancer progression. The award period is from September 1, 2023 to August 31, 2025. Brigham & Women's Hospital Inc. has previously conducted biomedical research and provided...